Geriatrics
Feature
Biogen plans to submit application to FDA for Alzheimer’s drug aducanumab
The company’s hopes lie with a secondary analysis of high-dose patients from two failed trials.
Opinion
Flu vaccine: Larger impact on influenza burden than you thought?
Even the current modestly effective flu vaccines have significant benefit, protecting U.S. populations from serious disease and death.
Conference Coverage
Agitation in psychosis: Still no ‘magic bullet’
SAN DIEGO – Some evidence supports various treatments, including antipsychotics, Dr. Marc Agronin said.
Feature
BP screening nearly universal among Medicare enrollees
Beneficiary snapshot looks at use of services and other key metrics.
Conference Coverage
Osteoporosis remains a costly burden to older U.S. adults
ORLANDO – Older women and minorities continue to bear the brunt of the burden of fragility fractures in the United States.
From the Journals
How does alcohol intake affect dementia risk in older adults?
The association may be more consistently adverse in adults with mild cognitive impairment.
Conference Coverage
Lumbar spine BMD, bone strength benefits persist after romosozumab-to-alendronate switch
ORLANDO – The effects occurred as early as month 6 and were sustained beyond 12 months after the transition to alendronate.
Conference Coverage
Vitamin D does not improve bone density, structure in healthy patients
ORLANDO – Daily use for 2 years did not affect areal BMD in the whole body, femoral neck, total hip, or spine, or...
Conference Coverage
Project ECHO helps osteoporosis specialists connect with PCPs
ORLANDO – Health care providers who participated in the ECHO program became more confident in 20 different domains...
From the Journals
Daily polypill lowers BP, cholesterol in underserved population
The regimen’s simplicity and low cost may overcome barriers to treatment, such as lack of income, underinsurance, and difficulty attending clinic...
From the Journals
Older IBD patients are most at risk of postdischarge VTE
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.